- On July 23, 2025, Hess Corporation (NYSE:HES) was removed as a constituent from the FTSE All-World Index, a widely tracked global equity benchmark.
- This index removal may prompt significant trading adjustments, especially by index-tracking funds and institutional investors managing portfolios aligned with benchmark indices.
- We'll examine how Hess's removal from the index could impact its visibility to institutional investors and shape the company's investment narrative.
These 15 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
What Is Hess' Investment Narrative?
For Hess shareholders, the big-picture story has shifted now that the company is no longer a constituent of major benchmark indices such as the FTSE All-World. Previously, the main catalysts and risks centered around the finalization of the Chevron merger, steady production guidance, and dividend reliability, with financial results showing falling revenue and earnings but still maintaining positive net income and high quality earnings. The index removals, occurring immediately after the merger, could prompt trading by index-tracking funds but are now largely a formality, aligning with Hess’s change in ownership status. In the short term, this likely doesn't affect core catalysts, namely integration progress with Chevron and quarterly results, but may limit visibility to certain institutional investors. Existing risks, such as the lack of share buybacks, high debt levels, and elevated valuation multiples versus industry peers, remain at the forefront. Institutional demand and broader market recognition could diminish, but the fundamentals driving Hess’s underlying performance persist.
But could reduced index visibility amplify existing risks for remaining retail shareholders? Despite retreating, Hess' shares might still be trading above their fair value and there could be some more downside. Discover how much.Exploring Other Perspectives
Explore 5 other fair value estimates on Hess - why the stock might be worth over 4x more than the current price!
Build Your Own Hess Narrative
Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Hess research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Hess research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Hess' overall financial health at a glance.
Ready To Venture Into Other Investment Styles?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- The end of cancer? These 25 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
- AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- The latest GPUs need a type of rare earth metal called Dysprosium and there are only 25 companies in the world exploring or producing it. Find the list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Hess might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com